Our PDX tumor samples BJ01 and BJ02 were deriv from TN breast cancer, BJ11 and BJ26 were HER2+/HR− breast cancer, and BJ44 was HER2+/ER+ breast cancer. This evidence concerns the gene ERBB2 and breast cancer.